- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06373107
Investigating Effects of High-intensity Gait Training on Gait, Balance and Depression Post-stroke
Investigating Effects of High-intensity Gait Training on Gait Function, Balance and Depression Following Stroke and the Impact of Social Determinants of Health and Depression on Patients' Adherence to Physical Therapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purpose of this research is to study the improvements from walking practice that is vigorous enough to keep participants' heart rate over a certain target level during their physical therapy sessions. The investigators want to know about improvement in participants' walking function and mental health after 20 interventions. The study also aims to evaluate if participants' mental health, social support, and health literacy affect their attendance at physical therapy sessions.
The findings from this study will help the researchers and clinicians decide how to help people with stroke better. Further, the findings will determine how depressive symptoms, health literacy, and other factors such as language and education affect attendance to therapy.
About 24 subjects will take part in this research.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Allentown, Pennsylvania, United States, 18104-2310
- Lehigh Valley Health Network Outpatient Neurologic Rehab
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- English or Spanish speaking
- A diagnosis of stroke (intracerebral hemorrhage or acute ischemic stroke)
- Referred to LVHN Outpatient Neurologic Rehab (hereafter referred to as outpatient PT)
Exclusion Criteria:
- Unable to follow 1-step commands
- > 220 pounds (100 kg)
- Height < 5'0" or > 6'4"
- Unable to take a few steps with assistance
- A score of ≥ 50/56 on Berg Balance Scale (BBS)
- A score of ≥ 26/30 on Functional Gait Assessment (FGA)
- Resting blood pressure >180/110 mmHg
- Resting heart rate > 120 bpm
- Severe cardiac disease (New York Heart Association Classification IV)
- Severe spasticity (Modified Ashworth score > 3)
- Unstable spine or unhealed pelvic/limb fractures
- Active heterotrophic ossification impacting lower extremity range of motion
- Significant lower or upper extremity contractures
- Inability to achieve neutral ankle dorsiflexion with 12° of knee flexion
- Pregnancy
- Colostomy
- Poor skin integrity
- Unresolved deep vein thrombosis
- Lower limb prosthesis or amputation
- Leg length discrepancies > 0.5 inches for upper legs, 0.75 inches for lower legs
- ROM restrictions preventing normal, reciprocal gait
- Inability to stand for > 3 minutes due to pain or orthostatic hypotension
- Pusher syndrome
- Cortical blindness
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity gait training
Participants will receive 20 sessions of vigorous walking practice.
These sessions are 2-3 times a week.
|
Participants will practice walking that is vigorous enough to keep their heart rate over a certain level during their physical therapy sessions.
During the sessions, participants will walk and step vigorously enough to keep the heart rate between 60-80% of their maximum heart rate.
Maintaining this heart rate during exercise helps to improve heart health and walking, which can affect people after a stroke.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
3-meter backwards walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
Measures backward gait velocity
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
6-minute walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
Measures aerobic capacity and endurance
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
10-meter walk test
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
Measures forward gait velocity
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Surface electromyography (EMG)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
Electromyographical recording of 8 leg muscles () is done during forward and backward walking tests.The EMG will be recorded during 3-meter Backward Walk Test, 6-minute Walk Test, and 10-meter Walk Test in all participants
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Berg Balance Scale
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
a 14-item objective measure that assesses static balance and fall risk in adults.
Berg balance scale scoring ranges from 0 to 56, with higher scores mean a better outcome.
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Functional Gait Assessment
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
This scale assess postural stability during walking and assesses an individual's ability to perform multiple motor tasks while walking.
Scoring for each FGA item ranges from 0 for severe impairment to 3 for normal performance.
The highest score possible is 30, with higher scores correlating better gait function.
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Borg Rating Scale of Perceived Exertion (RPE)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
RPE is used to prescribe and monitor exercise intensity and correlates well with physiological measures of exercise intensity, including heart rate.
The Borg Rating Scale of Perceived Exertion will be measured in all participants at the completion of 6 Minute Walk test.
It ranges from 6 to 20, where 6 means "no exertion at all" and 20 means "maximal exertion."
A lower score indicates a better exercise endurance.
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Patient Health Questionnaire (PHQ-9)
Time Frame: Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
Depressive symptom questionnaire.
As a severity measure, the PHQ-9 score can range from 0 to 27, since each of the 9 items can be scored from 0 (not at all) to 3 (nearly every day).
A lower score indicates less depressive symptoms.
|
Pre-, mid- (week 5) and post-intervention (within 2 weeks after the conclusion of intervention)
|
|
Rate of patient attendance (Compliance) to physical therapy
Time Frame: Participant's attendance to physical therapy is tracked throughout the intervention sessions.
|
Greater than or equal to 80% attendance to physical therapy is considered compliance to physical therapy.
|
Participant's attendance to physical therapy is tracked throughout the intervention sessions.
|
|
Newest Vital Sign
Time Frame: Pre-intervention (baseline)
|
The NVS is a 6-question screening tool that identifies participants' risk of low or limited health literacy based on interpreting an ice cream nutrition label.
It is available from Pfizer Pharmaceutical Company.
The level of health literacy for each individual will be categorized based on the scores: a score of 0-1 suggests a high likelihood of limited literacy, a score of 2-3 indicates the possibility of limited literacy, and a score of 4-6 almost always indicates adequate literacy.
This categorical variable will be used to determine the association with adherence to physical therapy.
|
Pre-intervention (baseline)
|
|
Multidimensional Scale of Perceived Social Support (MSPSS)
Time Frame: Pre-intervention (baseline)
|
The MSPSS is a 12-item self-administered scale that measures social support.
It contains 12-items, rated on a 7-point Likert-type scale, ranging from 1 "very strongly disagree" to 7 "very strongly agree."
The scale was divided into 3 subscales: family, friends, and significant other, with each section consisting of 4 items.
The response scale ranges from 12 to 84.
Higher scores indicate a greater family social support.
|
Pre-intervention (baseline)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Soo Yeon Sun, PhD, Alvernia University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2117651-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on High intensity gait training
-
Riphah International UniversityCompleted
-
Hunter College of City University of New YorkRecruiting
-
Oslo University HospitalSunnaas Rehabilitation Hospital; Indiana University School of Medicine; Norwegian... and other collaboratorsCompleted
-
Alvernia UniversityGood Shepherd Rehabilitation NetworkTerminatedStroke | Gait, HemiplegicUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Sunnyview Rehabilitation HospitalTerminatedCerebral Vascular AccidentUnited States
-
Indiana UniversityRecruiting
-
VA Office of Research and DevelopmentNorthwestern UniversityRecruitingChronic Hemiparetic StrokeUnited States
-
Hasselt UniversityRecruitingChronic Low-back Pain | Telerehabilitation | Exercise TherapyBelgium